Assured Home Health, Hospice & Home Care 2120 Northpark Street, Suite A, Centralia, WA, 98531 | |
(360) 330-2640 |
News Archive
In connection with the American Cancer Society's 2010 Great American Smokeout®, Target is launching a month-long Celebrate Smoke-free campaign designed to support guests and team members in their efforts to quit smoking.
A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1.
This past week, more than 200 airlines and in-flight content delegates arrived in Paris for the airline industry's only global in-flight content marketplace event, the Airline Passenger Experience Association (APEX) MultiMedia Market.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Pacific Northwest National Laboratory will lead a $10 million, five-year multi-institutional National Institutes of Health study to devise 3-D imaging and computational models of unsurpassed detail of respiratory systems in humans and other mammals, PNNL announced today.
› Verified 5 days ago
Name | Assured Home Health, Hospice & Home Care |
---|---|
Location | 2120 Northpark Street, Suite A, Centralia, Washington |
Hospice ID | 501512 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 200 |
News Archive
In connection with the American Cancer Society's 2010 Great American Smokeout®, Target is launching a month-long Celebrate Smoke-free campaign designed to support guests and team members in their efforts to quit smoking.
A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1.
This past week, more than 200 airlines and in-flight content delegates arrived in Paris for the airline industry's only global in-flight content marketplace event, the Airline Passenger Experience Association (APEX) MultiMedia Market.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Pacific Northwest National Laboratory will lead a $10 million, five-year multi-institutional National Institutes of Health study to devise 3-D imaging and computational models of unsurpassed detail of respiratory systems in humans and other mammals, PNNL announced today.
› Verified 5 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.8 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.8 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.8 | 97.3 |
Patients who got timely treatment for shortness of breath | 99.6 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
In connection with the American Cancer Society's 2010 Great American Smokeout®, Target is launching a month-long Celebrate Smoke-free campaign designed to support guests and team members in their efforts to quit smoking.
A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1.
This past week, more than 200 airlines and in-flight content delegates arrived in Paris for the airline industry's only global in-flight content marketplace event, the Airline Passenger Experience Association (APEX) MultiMedia Market.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Pacific Northwest National Laboratory will lead a $10 million, five-year multi-institutional National Institutes of Health study to devise 3-D imaging and computational models of unsurpassed detail of respiratory systems in humans and other mammals, PNNL announced today.
› Verified 5 days ago
Home Health Aides | 7.8 |
Counselors | 5.6 |
Licensed Practical or Vocational Nurses | 6 |
Medical Social Workers | 4.2 |
Physicians | 4.2 |
Registered Nurses | 23 |
Other Personnel | 3 |
Total Employees | 53.8 |
---|
News Archive
In connection with the American Cancer Society's 2010 Great American Smokeout®, Target is launching a month-long Celebrate Smoke-free campaign designed to support guests and team members in their efforts to quit smoking.
A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1.
This past week, more than 200 airlines and in-flight content delegates arrived in Paris for the airline industry's only global in-flight content marketplace event, the Airline Passenger Experience Association (APEX) MultiMedia Market.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Pacific Northwest National Laboratory will lead a $10 million, five-year multi-institutional National Institutes of Health study to devise 3-D imaging and computational models of unsurpassed detail of respiratory systems in humans and other mammals, PNNL announced today.
› Verified 5 days ago
Registered Nurses | 1 |
Total Volunteers | 1 |
---|
News Archive
In connection with the American Cancer Society's 2010 Great American Smokeout®, Target is launching a month-long Celebrate Smoke-free campaign designed to support guests and team members in their efforts to quit smoking.
A new therapy to treat spinal cord injuries in people who have lost all motor and sensory function below the injury site shows additional motor function improvement at 6-months and 9-months following treatment with 10 million AST-OPC1.
This past week, more than 200 airlines and in-flight content delegates arrived in Paris for the airline industry's only global in-flight content marketplace event, the Airline Passenger Experience Association (APEX) MultiMedia Market.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on diseases of epidemic potential, announced today that SQ109, its lead drug candidate for the treatment of tuberculosis (TB), was the first drug approved for evaluation in a newly awarded clinical program contract to Dynport Vaccine Company LLC and Quintiles Transnational.
Pacific Northwest National Laboratory will lead a $10 million, five-year multi-institutional National Institutes of Health study to devise 3-D imaging and computational models of unsurpassed detail of respiratory systems in humans and other mammals, PNNL announced today.
› Verified 5 days ago
Assured Home Health, Hospice & Home Care Location: 2120 Northpark Street, Suite A, Centralia, Washington, 98531 Phone: (360) 330-2640 |